Rel-1-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]-Ethanone-D3; rel-1-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]ethanone-d3; cis-1-Acetyl-d3-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine; (+/-)-Ketoconazole-d3; Brizoral-d3; Fungarest-d3; Fungoral-d3; Ketoderm-d3; Ketoisdin-d3; Ketozoral-d3; Nizoral-d3; Nizral-d3; Onofin K-d3; Orifungal M-d3; Panfungol-d3; R 41400-d3
Ketoconazole-d3 is a fully characterized chemical compound used as a reference standard of API Ketoconazole. The standard offered is compliant with regulatory guidelines. Ketoconazole-d3 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1217766-70-5
